Anannya Patwari

Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

Meera Mohan, Jorge Monge, Nishi Shah et al. · Blood Cancer Journal · 2024 · 82 citations · Full text

Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience

Vineel Bhatlapenumarthi, Anannya Patwari, Antoine Harb · Journal of Cancer Research and Clinical Oncology · 2021 · 52 citations · Full text

Autoimmune Disease, Immunology, Vaccine Trial +10

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma

Meera Mohan, Anikó Szabó, Anannya Patwari et al. · Bone Marrow Transplantation · 2024 · 19 citations

Cell Therapy, Autoimmune Disease, Immunology +7

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

Meera Mohan, Anikó Szabó, Heloise Cheruvalath et al. · Blood Cancer Journal · 2025 · 15 citations · Full text

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart et al. · Blood · 2024 · 12 citations